Cyclic Oral Methylprednisolone Trial in Multiple Sclerosis
NCT01305837
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Progressive Multiple Sclerosis
Interventions
DRUG:
methylprednisolone
Sponsor
Rigshospitalet, Denmark